Improved diagnosis of colorectal cancer using combined biomarkers including Fusobacterium nucleatum, fecal occult blood, transferrin, CEA, CA19‐9, gender, and age

BACKGROUND: Conventional blood and stool tests are normally used for early screening of colorectal cancer (CRC) but the accuracy and efficiency remain to be improved. Recent findings suggest Fusobacterium nucleatum to be a biomarker for CRC. This study evaluated the role of F. nucleatum and develope...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Ran, Xia, Dongge, Chen, Yingwei, Kai, Zhentian, Ruan, Fangying, Xia, Chaoran, Gong, Jingkai, Wu, Jun, Wang, Xueliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10358236/
https://www.ncbi.nlm.nih.gov/pubmed/37162269
http://dx.doi.org/10.1002/cam4.6067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10358236/
https://www.ncbi.nlm.nih.gov/pubmed/37162269
http://dx.doi.org/10.1002/cam4.6067

Ejemplares similares